Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nucleoside‐modified messenger RNA COVID‐19 vaccine platform

6 Mar 2021

Abstract excerpt

On March 11, 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic; from that date, the vaccine race has begun, and many technology platforms to develop a specific and effective COVID-19 vaccine have been launched in several clinical trials (protein subunit, RNA-based, DNA-based, replicating viral vector, nonreplicating viral vector, inactivated virus, live attenuated virus,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33675239
DOI: 10.1002/jmv.26924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nucleoside‐modified messenger RNA COVID‐19 vaccine platformPMID 33675239Read ↗

Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemicSemantic proximity Read ↗

Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19)Semantic proximity Read ↗

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2Semantic proximity Read ↗

Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development ArenaSemantic proximity Read ↗

Perspectives on RNA Vaccine Candidates for COVID-19Semantic proximity Read ↗

Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19Semantic proximity Read ↗

Nucleic Acid Vaccines against SARS-CoV-2Semantic proximity Read ↗

mRNA Vaccines Five Years After COVID-19: Lessons in Platform Design, Real-World Effectiveness, and EquitySemantic proximity Read ↗

mRNA-based modalities for infectious disease managementSemantic proximity Read ↗

Development and application of ribonucleic acid therapy strategies against COVID-19Semantic proximity Read ↗

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An OverviewSemantic proximity Read ↗

The Critical Contribution of Pseudouridine to mRNA COVID-19 VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.